Peer-influenced content. Sources you trust. No registration required. This is HCN.
Annals of Internal Medicine
A 509,926-patient Medicare cohort found that recombinant herpes zoster vaccination was associated with a 5.8 percentage point reduction in 4-year dementia risk among older adults following skilled-nursing facility admission, adding to a growing body of observational evidence linking RZV to cognitive protection.
Family Medicine/General Practice June 22nd 2026
Epoch Health
This study underscores the importance of a nuanced approach when considering the RZV vaccine for patients with a history of ocular shingles, as it may increase the risk of recurrence. It calls for a balanced assessment of the vaccine’s benefits against potential risks in this specific patient population.
Allergy & Immunology March 6th 2024
ACP Internist
This 62-year-old man had a lung transplant 3 years previously for IPF and is on tacrolimus, mycophenolate, and prednisone. Which therapy is most appropriate for their zoster outbreak? IV acyclovir Oral famciclovir Oral valacyclovir Herpes zoster vaccine
Allergy & Immunology January 19th 2023